Ayantika (Annie) Ghosh

• Lead diligence, agreement negotiation, and technology transfer processes, aligning R&D objectives with business strategies.
• Built a robust pipeline of partnerships by cultivating relationships with global institutions and industry leaders and execute licensing agreements with the entities to drive innovation and growth.
• Collaborate across departments to ensure deals align with long-term strategic goals.

Key Accomplishments:

• Successfully negotiated and closed multiple high-value licensing agreements (with pharmaceuticals and animal health companies), enabling key collaborations.
• Led a strategic stakeholder engagement initiative, resulting in a 30% increase in agreement flow.

• Directed end-to-end commercialization for life sciences technologies, driving market outreach, licensing, and alliance building.
• Evaluated intellectual property for market readiness and developed actionable growth strategies for Purdue technologies.
• Conducted comprehensive market research and product pipeline analysis to identify life-science industry trends, and potential areas of commercialization
• Negotiated and executed complex agreements, fostering collaborations with global industry partners.

Key Accomplishments:

• Achieved a 40% increase in licensing collaboration by implementing targeted market outreach strategies.
• Secured three major collaborations with pharma & drug development companies, resulting in potential licensing deals.

• Identified high-potential technologies for commercialization, driving strategies that secured over $500,000 in funding.
• Developed market entry strategies and facilitated industry partnerships, leading to successful licensing agreements.
• Provided strategic consulting to faculty inventors to align research with commercial goals.

Key Accomplishments:

• Coordinated funding applications that secured over $500,000 for early-stage technology development.
• Established a collaboration that resulted in a technology option agreement for a pediatric medical device.

• Conceptualized and led independent studies in areas including: a) Cellular signaling pathways and bile acid transport regulation in Crohn's Disease. b) Stem cell-based modeling and drug development studies in neurodevelopmental disorders. c) Stem cell based rare liver disease modeling and experimental therapies via liver cell transplantation, and in vivo reprogramming of injured cells.
• Collaborated effectively with cross-functional teams, including researchers, doctors, and collaborators, ensuring regular reporting of technical and design reviews to stakeholders.
• Provided strategic input for experimental designs and project roadmaps to align with project goals.

Key Accomplishments:

• Secured a private research grant worth $50,000 from the Stanley Foundation, USA.
• Co-authored with PI and secured R21 research proposal funding of $200,000 from NIH, USA.
• Published 14 peer-reviewed papers and presented as an invited speaker at four international conferences.

• Conducted competitive market analyses and developed strategic recommendations for emerging medical devices and therapies.
• Delivered actionable insights to optimize fund allocation for portfolio companies.

Key Accomplishments:

• Conducted a comprehensive market entry analysis for a heart monitoring device, resulting in the adoption of a new business model by a start-up.
• Identified key growth opportunities in the chronic liver disease management market, influencing investment decisions.